Help ?

IGMIN: We're glad you're here. Please click 'create a new query' if you are a new visitor to our website and need further information from us.

If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click 'take me to my Query.'

Search

Organised by  IgMin Fevicon

Regional sites

Browse by Subjects

Welcome to IgMin Research – an Open Access journal uniting Biology, Medicine, and Engineering. We’re dedicated to advancing global knowledge and fostering collaboration across scientific fields.

Browse by Sections

At IgMin Research, we bridge the frontiers of Biology, Medicine, and Engineering to foster interdisciplinary innovation. Our expanded scope now embraces a wide spectrum of scientific disciplines, empowering global researchers to explore, contribute, and collaborate through open access.

Special Issues

Our mission is to build a collaborative platform that merges expertise for rapid knowledge gains.

Members

Our mission is to build a collaborative platform that merges expertise for rapid knowledge gains.

Articles

Our mission is to build a collaborative platform that merges expertise for rapid knowledge gains.

Explore Content

Our mission is to build a collaborative platform that merges expertise for rapid knowledge gains.

Identify Us

Our mission is to build a collaborative platform that merges expertise for rapid knowledge gains.

IgMin Corporation

Welcome to IgMin, a leading platform dedicated to enhancing knowledge dissemination and professional growth across multiple fields of science, technology, and the humanities. We believe in the power of open access, collaboration, and innovation. Our goal is to provide individuals and organizations with the tools they need to succeed in the global knowledge economy.

Publications Support
[email protected]
E-Books Support
[email protected]
Webinars & Conferences Support
[email protected]
Content Writing Support
[email protected]
IT Support
[email protected]

Search

Select Language

Explore Section

Content for the explore section slider goes here.

Table of Contents

Table of Contents at IgMin Research

Our mission is to build a collaborative platform that merges expertise for rapid knowledge gains.

Article Explorer

Search by
Clear

All Articles
Most Recent Most Viewed Most Downloaded
1 of 254 results
In-silico analysis of Smilax anceps Compounds Targeting Estrogen Receptor Alpha and Aromatase for Follicle Stimulation in Infertility Therapy
Research Article October 30, 2026

In-silico analysis of Smilax anceps Compounds Targeting Estrogen Receptor Alpha and Aromatase for Follicle Stimulation in Infertility Therapy

Article Preview Metrics Cite
Published: October 30, 2026 (21d) publication certificate
In-silico analysis of Smilax anceps Compounds Targeting Estrogen Receptor Alpha and Aromatase for Follicle Stimulation in Infertility Therapy Research Article

In-silico analysis of Smilax anceps Compounds Targeting Estrogen Receptor Alpha and Aromatase for Follicle Stimulation in Infertility Therapy

OS Bakare*1AT Kolawole2, MM Olusanya2, SA Praise*2 and AB Awolesi2

Infertility is a primary global health concern, with ovulatory dysfunction being a primary cause. Both estrogen receptor alpha (ERα) and Aromatase are recognized as influential factors in the stimulation of the follicle and, thus, are promising candidates for novel infertility treatment strategies. The application of pharmaceutical approaches like clomiphene citrate, Letrozole, and Anastrozole is of great value but not without challenge, which highlights the need for new, safer approaches. The current study is designed to apply an in-silico technique based on the bioactivity of the compounds found in Smilax anceps to assess the alteration of the ERα and Aromatase modulatory activity.
Molecular docking analyses revealed that Rutin (-15.499 kcal/mol) and Naringin (-12.45 kcal/mol) exhibited superior binding affinities to Aromatase compared to standard drugs. Quercetin (-11.032 kcal/mol) demonstrated strong interaction with ERα, surpassing clomiphene citrate (-10.872 kcal/mol). MM-GBSA calculations further validated the binding efficiency of these compounds. Density Functional Theory (DFT) analysis provided insights into molecular stability and reactivity, while ADMET predictions indicated favorable pharmacokinetic properties for select compounds.
These findings suggest that bioactive compounds from Smilax anceps, particularly Rutin and Quercetin, exhibit strong potential as alternative or adjunct therapies for infertility treatment. However, comprehensive in-vitro and in-vivo investigations are essential to confirm their therapeutic efficacy, safety, and clinical applicability.